Search
Back

Niraparib Tosylate

CAS 1038915-60-4
Niraparib Tosylate

General Information

Niraparib, sold under the brand name Zejula, is a cytotoxic targeted therapy. This medication is classified as a PARP (poly ADP ribose polymerase) inhibitor.


About the API

Technology Synthetic
Therapeutic category Oncology
Available formulations Oral Solid
Regulations
  • Japan DMF
  • Korea DMF
  • US DMF

The information detailed herein, including that with regard to active pharmaceutical ingredients , their use in treatments and possible mechanism(s) of action, was all obtained from public sources.

For more information on our services and products – including product suitability, intended uses and current availability – please contact Teva api Customer Service. CAS Registry Number is a Registered Trademark of the American Chemical Society. This webpage and any reference to the above product is to be read within the meaning and terms of the Legal Notes.